SEC Form 4 · accession 0001127602-15-024376
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Aug 6, 2015
Accepted (ET)
Aug 6, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 6, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF3 | Aug 6, 2015 | S | 2,474 | $163.9206 | D | 1,881 | D | |
| Common StockF4 | Aug 6, 2015 | S | 1,641 | $164.33 | D | 240 | D | |
| Common StockF2 | Aug 6, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF5 | Aug 6, 2015 | S | 2,547 | $159.3113 | D | 3,240 | D | |
| Common StockF6 | Aug 6, 2015 | S | 700 | $160.0086 | D | 2,540 | D | |
| Common StockF7 | Aug 6, 2015 | S | 600 | $161.7183 | D | 1,940 | D | |
| Common Stock | Aug 6, 2015 | S | 200 | $162.49 | D | 1,740 | D | |
| Common StockF8 | Aug 6, 2015 | S | 700 | $164.1714 | D | 1,040 | D | |
| Common StockF9 | Aug 6, 2015 | S | 400 | $165.755 | D | 640 | D | |
| Common StockF10 | Aug 6, 2015 | S | 400 | $166.7175 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $34.56 | Aug 6, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 56,193 | D |
| Stock OptionsF2 | $30.75 | Aug 6, 2015 | M | 5,547 | D | Dec 26, 2009 | Dec 31, 2017 | Common Stock | 5,547 | 410,443 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F10This transaction was executed in multiple trades at prices ranging from $166.53 to $17.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $163.32 to $164.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $164.33 to $164.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $158.82 to $159.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $159.89 to $160.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $161.20 to $162.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $163.57 to $164.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $165.41 to $166.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.